• user warning: Table './fnndrupaldev/term_node' is marked as crashed and last (automatic?) repair failed query: SELECT t.* FROM term_node r INNER JOIN term_data t ON r.tid = t.tid INNER JOIN vocabulary v ON t.vid = v.vid WHERE r.vid = 488082 ORDER BY v.weight, t.weight, t.name in /var/www/www.fnno.com/htdocs/modules/taxonomy/taxonomy.module on line 617.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT COUNT(sid) AS count FROM sessions WHERE timestamp >= 1417230773 AND uid = 0 in /var/www/www.fnno.com/htdocs/includes/session.inc on line 111.
  • user warning: Table './fnndrupaldev/sessions' is marked as crashed and last (automatic?) repair failed query: SELECT DISTINCT u.uid, u.name, s.timestamp FROM users u INNER JOIN sessions s ON u.uid = s.uid WHERE s.timestamp >= 1417230773 AND s.uid > 0 ORDER BY s.timestamp DESC in /var/www/www.fnno.com/htdocs/modules/user/user.module on line 765.

Buyers Accumulating Shares of Amarin on 1.6x Above-Average Volume (AMRN)

Published on Fri, 04/26/2013 - 13:16
By Peter Chu

Amarin shares are trading on heavy volume today, having risen 5.9% to $6.77. Approximately 5.4 million shares have changed hands today vs. average 30-day volume of 3.4 million shares. Unusually high volume can signify a potential turning point or validate a breakout.

In the past 52 weeks, shares of Amarin have traded between a low of $6.34 and a high of $15.96 and are now at $6.77, which is 7% above that low price. The 200-day and 50-day moving averages have moved 1.22% lower and 1.41% lower over the past week, respectively.

Amarin (NASDAQ:AMRN) has potential upside of 125.8% based on a current price of $6.77 and analysts' consensus price target of $15.29. The stock should find initial resistance at its 50-day moving average (MA) of $7.78 and further resistance at its 200-day MA of $10.48.

Amarin Corporation PLC is a clinical-stage biopharmaceutical company. The Company researches, develops, and commercializes drugs for the treatment of hypertriglyceridemia, central nervous system disorders, and cardiovascular diseases.

By Peter Chu
pchu@fnno.com

Latest News from FNNO

Recent 52-Week High Exceeded in Shares o...

Shares of Xcel Energy (NYSE:XEL) traded at a new 52-week high today of $34.10. So far ...

Wyndham Worldwide: The Winning Streak Co...

Shares of Wyndham Worldwide (NYSE:WYN) traded today at $84.06, breaking its 52-week hig ...

Shares of Western Union Have Risen Above...

Western Union (NYSE:WU) traded at a new 52-week high today of $18.66. So far today app ...

Watch for Continued Gains in Shares of A...

Aqua America (NYSE:WTR) traded today at a new 52-week high of $26.90. Approximately 43 ...

W&T Offshore: The Losing Streak Continue...

Shares of W&T Offshore (NYSE:WTI) traded at a new 52-week low today of $7.52. Approxim ...

Shares of West Pharmaceutical Services R...

West Pharmaceutical Services (NYSE:WST) traded today at a new 52-week high of $53.28. ...

Warren Resources Looks to Continue to Tr...

Warren Resources (NASDAQ:WRES) traded at a new 52-week low today of $2.05. So far toda ...

Recent 52-Week High Exceeded in Shares o...

WR Berkley (NYSE:WRB) traded today at a new 52-week high of $52.77. Approximately 152, ...